-+ 0.00%
-+ 0.00%
-+ 0.00%

Orchestra BioMed shareholders approved 2026 annual meeting proposals

PUBT·06/23/2026 20:55:44
Listen to the news
Orchestra BioMed shareholders approved 2026 annual meeting proposals
  • Orchestra BioMed held its annual shareholder meeting on June 23, 2026.
  • Shareholders ratified Ernst & Young as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders adopted the 2026 Equity Incentive Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-076845), on June 23, 2026, and is solely responsible for the information contained therein.